November 01, 2022
November 06, 2022
October 18, 2022
November 01, 2022
Read MoreOctober 18, 2022
Read MoreNovember 06, 2022
Read MoreApril 17, 2024
The molecular diagnostics market size was valued at USD 15.42 billion in 2023 and is anticipated to uplift to USD 25.27 billion by 2032 registering a significant growth with a 5.3% CAGR (2024-2032). Report Highlights: Instruments and systems ex...
March 08, 2024
The newborn screening market size is estimated to grow from USD 3.23 billion in 2023 to anticipate around USD 5.96 billion by 2032, registering at a CAGR of 6.5% between 2024 and 2032. Report Highlights: Blood tests held a major chunk with 70% ...
March 04, 2024
The global autoimmune hepatitis diagnosis and treatment market size is estimated to grow from USD 14.03 billion in 2023 to surpass around USD 19.15 billion by 2032, registered at a CAGR of 3.3% between 2023 and 2032, as a result of the growing demand...
March 01, 2024
The hemato-oncology testing market size achieved a value of $3.17 billion in 2023 and is anticipated to reach $9.78 billion by 2033. Projections suggest a compound annual growth rate (CAGR) of 12.4% for the period of 2024 to 2033. Insight Highligh...
January 15, 2024
Report Highlights: The global stroke diagnostics and therapeutics market was valued at USD 34.45 billion in 2022. Projected market size is USD 66.41 billion by 2032. Estimated to grow at 7.2% CAGR from 2022 to 2032. The ischemic stroke segment ...
June 09, 2023
The global pancreatic cancer market size reached USD 2.05 billion in 2022 and is projected to reach around USD 7.4 billion by 2032, expanding at a CAGR of 13.7%, as a result of the rising prevalence of pancreatic cancer, and rising investment in the ...
May 23, 2023
The AI in cancer diagnostics market is estimated to grow from USD 892.23 million in 2022 at 9.35% CAGR (2023-2032) to reach an estimated USD 2,084.34 million by 2032 FDA published an updated list of around 178 new AI-based devices in July 2022 mak...
May 10, 2023
The global central lab market is estimated to grow from USD 3.1 billion in 2022 at 5.71% CAGR (2023-2032) to reach an estimated USD 5.4 billion by 2032, as a result of rising investment in R&D and rising demand for clinical trials. Pharmaceuti...
March 23, 2023
The global central lab market is estimated to grow from more than USD 3.1 billion in 2022 to reach an estimate of more than 5.4 billion by 2032, at a 5.71% CAGR between 2023 and 2032, as increasing clinical trials & increase in investment in rese...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com